JP2002502827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002502827A5 JP2002502827A5 JP2000530232A JP2000530232A JP2002502827A5 JP 2002502827 A5 JP2002502827 A5 JP 2002502827A5 JP 2000530232 A JP2000530232 A JP 2000530232A JP 2000530232 A JP2000530232 A JP 2000530232A JP 2002502827 A5 JP2002502827 A5 JP 2002502827A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- immunodeficiency virus
- human immunodeficiency
- protein
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7394398P | 1998-02-06 | 1998-02-06 | |
| US60/073,943 | 1998-02-06 | ||
| PCT/US1999/002503 WO1999039735A1 (en) | 1998-02-06 | 1999-02-04 | Live vaccine for human immunodeficiency virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002502827A JP2002502827A (ja) | 2002-01-29 |
| JP2002502827A5 true JP2002502827A5 (enExample) | 2006-03-23 |
Family
ID=22116747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000530232A Withdrawn JP2002502827A (ja) | 1998-02-06 | 1999-02-04 | ヒト免疫不全ウイルスに対する生ワクチン |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1061950B1 (enExample) |
| JP (1) | JP2002502827A (enExample) |
| KR (1) | KR20010040618A (enExample) |
| CN (1) | CN1216640C (enExample) |
| AT (1) | ATE287727T1 (enExample) |
| AU (1) | AU744730B2 (enExample) |
| CA (1) | CA2320489A1 (enExample) |
| DE (1) | DE69923439D1 (enExample) |
| IL (1) | IL137680A0 (enExample) |
| NZ (1) | NZ506093A (enExample) |
| RU (1) | RU2223784C2 (enExample) |
| WO (1) | WO1999039735A1 (enExample) |
| ZA (1) | ZA99912B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802426B1 (fr) | 1999-12-15 | 2004-04-02 | Neovacs | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires |
| AU8640501A (en) * | 2000-07-31 | 2002-02-13 | Univ Yale | Innate immune system-directed vaccines |
| KR100447530B1 (ko) * | 2001-08-14 | 2004-09-08 | 한국과학기술원 | ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법 |
| EP1670505B1 (en) | 2003-09-18 | 2012-11-14 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Dna promoters and anthrax vaccines |
| ES2555544T3 (es) | 2006-03-07 | 2016-01-04 | Vaxinnate Corporation | Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas |
| CN101195823B (zh) * | 2007-11-20 | 2010-06-02 | 华东理工大学 | 细菌表面展示系统、方法及应用 |
| CN109207417A (zh) * | 2018-09-19 | 2019-01-15 | 湖北省农业科学院畜牧兽医研究所 | 鸡白痢-j亚群禽白血病双重平板凝集抗原及其制备方法 |
| JP2023516420A (ja) * | 2020-03-05 | 2023-04-19 | ユニヴァーシティー オブ メリーランド バルチモア | がんタンパク質抗原を発現するように操作された生チフス菌ベクターおよびその使用方法 |
| WO2025063261A1 (ja) * | 2023-09-22 | 2025-03-27 | 塩野義製薬株式会社 | ウイルス由来タンパク質をコードするポリヌクレオチド |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757013A (en) * | 1983-07-25 | 1988-07-12 | The Research Foundation Of State University Of New York | Cloning vehicles for polypeptide expression in microbial hosts |
| AU9179891A (en) * | 1990-12-19 | 1992-07-22 | Epitope, Inc. | Hiv reverse transcriptase vaccine |
| JP3100005B2 (ja) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | ヒト免疫不全ウィルス感染・増殖抑制剤 |
| AU3958895A (en) * | 1994-10-18 | 1996-05-06 | Board Of Regents, The University Of Texas System | Membrane expression of heterologous genes |
-
1999
- 1999-02-04 JP JP2000530232A patent/JP2002502827A/ja not_active Withdrawn
- 1999-02-04 CN CN998027014A patent/CN1216640C/zh not_active Expired - Fee Related
- 1999-02-04 EP EP99913808A patent/EP1061950B1/en not_active Expired - Lifetime
- 1999-02-04 DE DE69923439T patent/DE69923439D1/de not_active Expired - Fee Related
- 1999-02-04 AT AT99913808T patent/ATE287727T1/de not_active IP Right Cessation
- 1999-02-04 IL IL13768099A patent/IL137680A0/xx unknown
- 1999-02-04 CA CA002320489A patent/CA2320489A1/en not_active Abandoned
- 1999-02-04 WO PCT/US1999/002503 patent/WO1999039735A1/en not_active Ceased
- 1999-02-04 RU RU2000123173/15A patent/RU2223784C2/ru not_active IP Right Cessation
- 1999-02-04 NZ NZ506093A patent/NZ506093A/en unknown
- 1999-02-04 AU AU31801/99A patent/AU744730B2/en not_active Ceased
- 1999-02-04 KR KR1020007008489A patent/KR20010040618A/ko not_active Abandoned
- 1999-02-05 ZA ZA9900912A patent/ZA99912B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LeCureux et al. | Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens | |
| EP0732937B2 (en) | Non-toxic mucosal adjuvant | |
| Tacket et al. | Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159: H4 | |
| Almeida et al. | Nasal delivery of vaccines | |
| JP4179627B2 (ja) | コレラワクチンとしての欠失変異体 | |
| US6126938A (en) | Methods for inducing a mucosal immune response | |
| JP7426953B2 (ja) | 免疫原性組成物 | |
| JP2004512264A5 (enExample) | ||
| JPH10500958A (ja) | Ｈｅｌｉｃｏｂａｃｔｅｒの感染症の治療および予防 | |
| RU2000123173A (ru) | Живая вакцина против вируса иммунодефицита человека | |
| Stevceva et al. | Mucosal HIV vaccines: where are we now? | |
| CN101455846B (zh) | 脱乙酰壳聚糖递送系统组装的结核基因疫苗及其制备和应用 | |
| RU2223784C2 (ru) | Живая вакцина против вируса иммунодефицита человека | |
| US20090324638A1 (en) | Live bacterial vaccine | |
| RU2840971C1 (ru) | Способ создания рекомбинантного штамма энтерококка L3-SARS"XBB.1.5" на основе биологически активного штамма Enterococcus faecium L3 | |
| JP6216371B2 (ja) | ＹｅｒｓｉｎｉａｐｅｓｔｉｓＦ１−Ｖ融合タンパク質を発現するＳａｌｍｏｎｅｌｌａＴｙｐｈｉＴｙ２１ａおよびその使用 | |
| CN111012903A (zh) | 一种诱导粘膜定居性记忆t细胞形成及增殖的方法 | |
| GB2413327A (en) | Fusion proteins comprising E. coli antigens | |
| Vajdy | Induction of optimal immune responses against human immunodeficiency virus at mucosal portals of entry | |
| JP2002507118A (ja) | ヘリコバクターピロリＦｌｇＥポリペプチドからなるワクチン組成物 | |
| JP4875606B2 (ja) | ストレプトミセスから得られたワクチン組成物 | |
| Chamcha | Probiotics based approaches to target mucosal compartments: Potential novel approaches to HIV vaccine development | |
| Gheorghiu | The role of BCG vaccine in tuberculosis control | |
| WO2001083532A1 (en) | Helicobacter pylori antigens: fusion of fay 31 and hpa 44 | |
| Cooper et al. | Novel strategies for vaccination |